• 1
    Mosmann, T. R., Cherwinski, C., Bond, M. W., Giedlin, M. A. and Coffman, R. L., Two types of murine helper T cell clones. I. Definition according to profiles of lymphokine activities and secreted proteins. J. Immunol. 1986. 136: 23482357.
  • 2
    Romagnani, S., Human TH1 and TH2 subsets: doubt no more. Immunol. Today 1991. 12: 256257.
  • 3
    Romagnani, S., The Th1/Th2 paradigm. Immunol. Today. 1997. 18: 263266.
  • 4
    Annunziato, F., Cosmi, L., Manetti, R., Brugnolo, F., Parronchi, P., Maggi, E., Nagata, K. and Romagnani, S., Reversal of human allergen-specific CRTH2+T(H)2 cells by IL-12 or the PS-DSP30 oligodeoxynucleotide. J. Allergy Clin. Immunol. 2001. 108: 815821.
  • 5
    Hegazy, A. N., Peine, M., Helmstetter, C., Panse, I., Fröhlich, A., Bergthaler, A., Flatz, L. et al., Interferons direct Th2 cell reprogramming to generate a stable GATA-3(+)T-bet(+) cell subset with combined Th2 and Th1 cell functions. Immunity 2010. 32: 116128.
  • 6
    Cua, D. J., Sherlock, J., Chen, Y., Murphy, C. A., Joyce, B., Seymour, B., Lucian, L. et al., Interleukin-23 rather than interleukin-12 is the critical cytokine for autoimmune inflammation of the brain. Nature 2003. 421: 744748.
  • 7
    Dubin, P. J. and Kolls, J. K., Th17 cytokines and mucosal immunity. Immunol. Rev. 2008. 226: 160171.
  • 8
    Murphy, C. A., Langrish, C. L., Chen, Y., Blumenschein, W., McClanahan, T., Kastelein, R. A., Sedgwick, J. D. and Cua, D. J., Divergent pro- and anti-inflammatory roles for IL-23 and IL-12 in joint autoimmune inflammation. J. Exp. Med. 2003. 198: 19511958.
  • 9
    McGeachy, M. J., Chen, Y., Tato, C. M., Laurence, A., Joyce-Shaikh, B., Blumenschein, W. M., McClanahan, T. K. et al., The interleukin 23 receptor is essential for the terminal differentiation of interleukin 17-producing effector T helper cells in vivo. Nat. Immunol. 2009. 10: 314324.
  • 10
    Tato, C. M., Laurence, A. and O'Shea, J. J., Helper T cell differentiation enters a new era: le roi est mort; vive le roi. J. Exp. Med. 2006. 203: 809812.
  • 11
    Mangan, P. R., Harrington, L. E., O'Quinn, D. B., Helms, W. S., Bullard, D. C., Elson, C. O., Hatton, R. D. et al., Transforming growth factor-beta induces development of the T(H)17 lineage. Nature 2006. 441: 231234.
  • 12
    Veldhoen, M., Hocking, R. J., Atkinsm, C. J., Locksley, R. M. and Stockinger, B., TGF-beta in the context of an inflammatory cytokine milieu supports differentiation of IL-17-producing T cells. Immunity 2006. 25: 179189.
  • 13
    Huber, M., Brüstle, A., Reinhard, K., Guralnik, A., Walter, G., Mahiny, A., von Löw, E. and Lohoff M., IRF4 is essential for IL-21-mediated induction, amplification, and stabilization of the Th17 phenotype. Proc. Natl. Acad. Sci. USA 2008. 105: 2084620851.
  • 14
    Annunziato, F., Cosmi, L., Santarlasci, V., Maggi, L., Liotta, F., Mazzinghi, B., Parente, E. et al., Phenotypic and functional features of human Th17 cells. J. Exp. Med. 2007. 204: 18491861.
  • 15
    Cosmi, L., Maggi, L., Santarlasci, V., Capone, M., Cardilicchia, E., Frosali, F., Querci, V. et al., Identification of a novel subset of human circulating memory CD4(+) T cells that produce both IL-17A and IL-4. J. Allergy Clin. Immunol. 2010. 125: 222230.
  • 16
    Wang, Y. H., Voo, K. S., Liu, B., Chen, C. Y., Uygungil, B., Spoede, W., Bernstein, J. A. et al., A novel subset of CD4+TH2 memory/effector cells that produce inflammatory IL-17 cytokine and promote the exacerbation of chronic allergic asthma. J. Exp. Med. 2010. 207: 24792491.
  • 17
    Cosmi, L., De Palma, R., Santarlasci, V., Maggi, L., Capone, M., Frosali, F., Rodolico, G. et al., Human interleukin 17-producing cells originate from a CD161+CD4+T cell precursor. J. Exp. Med. 2008. 205: 19031916.
  • 18
    Kleinschek, M. A., Boniface, K., Sadekova, S., Grein, J., Murphy, E. E., Turner, S. P., Raskin, L. et al., Circulating and gut-resident human Th17 cells express CD161 and promote intestinal inflammation. J. Exp. Med. 2009. 206: 525534.
  • 19
    .Santarlasci, V., Maggi, L., Capone, M., Frosali, F., Querci, V., De Palma, R., Liotta, F. et al., TGF-beta indirectly favors the development of human Th17 cells by inhibiting Th1 cells. Eur. J. Immunol. 2009. 39: 207215.
  • 20
    Marks, B. R., Nowyhed, H. N., Choi, J. Y., Poholek, A. C., Odegard, J. M., Flavell, R. A. and Craft, J., Thymic selfreactivity selects natural interleukin 17-producing T cells that can regulate peripheral inflammation. Nat. Immunol. 2009. 10: 11251132.
  • 21
    Das, J., Ren, G., Zhang, L., Roberts, A. I., Zhao, X., Bothwell, A. L., Van Kaer, L. et al., Transforming growth factor beta is dispensable for the molecular orchestration of Th17 cell differentiation. J. Exp. Med. 2009. 206: 24072416.
  • 22
    Sutton, C., Brereton, C., Keogh, B., Mills, K. H. and Lavelle, E. C., A crucial role for interleukin (IL)-1 in the induction of IL-17-producing T cells that mediate autoimmune encephalomyelitis. J. Exp. Med. 2006. 203: 16851691.
  • 23
    Annunziato, F. and Romagnani, S., Do studies in humans better depict Th17 cells? Blood 2009. 114: 22132219.
  • 24
    Doodes, P. D., Cao, Y., Hamel, K. M., Wang, Y., Farkas, B., Iwakura, Y. and Finnegan, A., Development of proteoglycan-induced arthritis is independent of IL-17. J. Immunol. 2008. 181: 329337.
  • 25
    Luger, D., Silver, P. B., Tang, J., Cua, D., Chen, Z., Iwakura, Y., Bowman, E. P. et al., Either a Th17 or a Th1 effector response can drive autoimmunity: conditions of disease induction affect dominant effector category. J. Exp. Med. 2008. 205: 799810.
  • 26
    Kroenke, M. A., Chensue, S. W. and Segal, B. M., EAE mediated by a non-IFN-γ/non-IL-17 pathway. Eur. J. Immunol. 2010. 40: 23402348.
  • 27
    Annunziato, F., Cosmi, L., Liotta, F., Maggi, E., Romagnani, S., Human Th17 cells: are they different from murine Th17 cells? Eur. J. Immunol. 2009. 39: 637640.
  • 28
    Lee, Y. K., Turner, H., Maynard, C. L., Oliver, J. R., Chen, D., Elson, C. O. and Weaver, C. T., Late developmental plasticity in the T helper 17 lineage. Immunity. 2009. 30: 92107.
  • 29
    Wei, G., Wei, L., Zhu, J., Zang, C., Hu-Li, J., Yao, Z., Cui, K. et al., Global mapping of H3K4me3 and H3K27me3 reveals specificity and plasticity in lineage fate determination of differentiating CD4+T cells. Immunity 2009. 30: 155167.
  • 30
    Mukasa, R., Balasubramani, A., Lee, Y. K., Whitley, S. K., Weaver, B. T., Shibata, Y., Crawford, G. E. et al., Epigenetic instability of cytokine and transcription factor gene loci underlies plasticity of the T helper 17 cell lineage. Immunity 2010. 32: 616627.
  • 31
    Lexberg, M. H., Taubner, A., Albrecht, I., Lepenies, I., Richter, A., Kamradt, T., Radbruch, A. and Chang, H. D., IFN-γ and IL-12 synergize to convert in vivo-generated Th17 into Th1/17 cells. Eur. J. Immunol. 2010; in press.
  • 32
    Martin-Orozco, N., Chung, Y., Chang, S. H., Wang, Y. H. and Dong, C., Th17 cells promote pancreatic inflammation but only induce diabetes efficiently in lymphopenic hosts after conversion into Th1 cells. Eur. J. Immunol. 2009. 39: 216224.
  • 33
    Bending, D., De La Peña, H., Veldhoen, M., Phillips, J. M., Uyttenhove, C., Stockinger, B. and Cooke, A., Highly purified Th17 cells from BDC2.5NOD mice convert into Th1-like cells in NOD/SCID recipient mice. J. Clin. Invest. 2009 Feb 2. pii: 37865. doi: 10.1172/JCI37865. [Epub ahead of print]
  • 34
    Nistala, K., Adams, S., Cambrook, H., Ursu, S., Olivito, B., de Jager, W., Evans, J. G. et al., Th17 plasticity in human autoimmune arthritis is driven by the inflammatory environment. Proc. Natl. Acad. Sci. USA 2010. 107: 1475114756.
  • 35
    Kurschus, F. C., Croxford, A. L., Heinen, A. P., Wörtge, S., Ielo, D. and Waisman, A., Genetic proof for the transient nature of the Th17 phenotype. Eur. J. Immunol. 2010. 40: 33363346.
  • 36
    Gottlieb, A., Menter, A., Mendelsohn, A., Shen, Y. K., Li, S., Guzzo, C., Fretzin, S. et al., Ustekinumab, a human interleukin 12/23 monoclonal antibody, for psoriatic arthritis: randomised, double-blind, placebo-controlled, crossover trial. Lancet 2009. 373: 633640.